BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Sanyou and Sinorda Partner for Innovative Drug Research

According to the cooperation agreement, leveraging Sanyou's world-leading core technology platform for integrated R&D and preclinical development of in...

August 23, 2023 | News

CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation

CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...

August 22, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

August 22, 2023 | Regulatory

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...

August 17, 2023 | News

Daewoong Pharmaceutical Introduces 'Fexuprazan' with Global Export to the Philippines

Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched in the Philippines o...

August 17, 2023 | News

Parexel & Partex Unite Artificial Intelligence and Big Data to Speed Drug Discovery

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, a...

August 16, 2023 | News

FDA Grants Priority Review for Cefepime-Taniborbactam to Treat cUTI

Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's N...

August 16, 2023 | News

Kelun-Biotech's Phase III Trial of SKB264 Meets Endpoint in Advanced TNBC

Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...

August 15, 2023 | News

TB Alliance and Remington Pharma Partner to Launch New Therapy for Drug-Resistant TB in Pakistan

Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license to market the anti-tubercul...

August 15, 2023 | News

CAS and Molecule.one Partner to Speed Up Drug Discovery

CAS, a division of the American Chemical Society specializing in scientific information solutions, and Molecule.one, a tech-bio leader in AI-based solution...

August 14, 2023 | News

First Patient Dosed in Phase III Prostate Cancer Imaging Study of TLX591-CDx in China

The Phase III Illuccix China study (ClinicalTrials.gov ID: NCT05847348) is a prospective, open-label, single-arm, multicenter study in Chinese...

August 11, 2023 | News

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it is collaborating with N...

August 11, 2023 | News

Pharming Enrolls First Patient in Japanese APDS Treatment Trial

Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been enrolled in its Phase ...

August 10, 2023 | News

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modi...

August 09, 2023 | News

Stay Connected